Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis

View through CrossRef
AbstractObjectiveTo determine if margin involvement is associated with distant recurrence and to determine the required margin to minimise both local recurrence and distant recurrence in early stage invasive breast cancer.DesignProspectively registered systematic review and meta-analysis of literature.Data sourcesMedline (PubMed), Embase, and Proquest online databases. Unpublished data were sought from study authors.Eligibility criteriaEligible studies reported on patients undergoing breast conserving surgery (for stages I-III breast cancer), allowed an estimation of outcomes in relation to margin status, and followed up patients for a minimum of 60 months. Patients with ductal carcinoma in situ only or treated with neoadjuvant chemotherapy or by mastectomy were excluded. Where applicable, margins were categorised as tumour on ink (involved), close margins (no tumour on ink but <2 mm), and negative margins (≥2 mm).Results68 studies from 1 January 1980 to 31 December 2021, comprising 112 140 patients with breast cancer, were included. Across all studies, 9.4% (95% confidence interval 6.8% to 12.8%) of patients had involved (tumour on ink) margins and 17.8% (13.0% to 23.9%) had tumour on ink or a close margin. The rate of distant recurrence was 25.4% (14.5% to 40.6%) in patients with tumour on ink, 8.4% (4.4% to 15.5%) in patients with tumour on ink or close, and 7.4% (3.9% to 13.6%) in patients with negative margins. Compared with negative margins, tumour on ink margins were associated with increased distant recurrence (hazard ratio 2.10, 95% confidence interval 1.65 to 2.69, P<0.001) and local recurrence (1.98, 1.66 to 2.36, P<0.001). Close margins were associated with increased distant recurrence (1.38, 1.13 to 1.69, P<0.001) and local recurrence (2.09, 1.39 to 3.13, P<0.001) compared with negative margins, after adjusting for receipt of adjuvant chemotherapy and radiotherapy. In five studies published since 2010, tumour on ink margins were associated with increased distant recurrence (2.41, 1.81 to 3.21, P<0.001) as were tumour on ink and close margins (1.44, 1.22 to 1.71, P<0.001) compared with negative margins.ConclusionsInvolved or close pathological margins after breast conserving surgery for early stage, invasive breast cancer are associated with increased distant recurrence and local recurrence. Surgeons should aim to achieve a minimum clear margin of at least 1 mm. On the basis of current evidence, international guidelines should be revised.Systematic review registrationCRD42021232115.
Title: Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis
Description:
AbstractObjectiveTo determine if margin involvement is associated with distant recurrence and to determine the required margin to minimise both local recurrence and distant recurrence in early stage invasive breast cancer.
DesignProspectively registered systematic review and meta-analysis of literature.
Data sourcesMedline (PubMed), Embase, and Proquest online databases.
Unpublished data were sought from study authors.
Eligibility criteriaEligible studies reported on patients undergoing breast conserving surgery (for stages I-III breast cancer), allowed an estimation of outcomes in relation to margin status, and followed up patients for a minimum of 60 months.
Patients with ductal carcinoma in situ only or treated with neoadjuvant chemotherapy or by mastectomy were excluded.
Where applicable, margins were categorised as tumour on ink (involved), close margins (no tumour on ink but <2 mm), and negative margins (≥2 mm).
Results68 studies from 1 January 1980 to 31 December 2021, comprising 112 140 patients with breast cancer, were included.
Across all studies, 9.
4% (95% confidence interval 6.
8% to 12.
8%) of patients had involved (tumour on ink) margins and 17.
8% (13.
0% to 23.
9%) had tumour on ink or a close margin.
The rate of distant recurrence was 25.
4% (14.
5% to 40.
6%) in patients with tumour on ink, 8.
4% (4.
4% to 15.
5%) in patients with tumour on ink or close, and 7.
4% (3.
9% to 13.
6%) in patients with negative margins.
Compared with negative margins, tumour on ink margins were associated with increased distant recurrence (hazard ratio 2.
10, 95% confidence interval 1.
65 to 2.
69, P<0.
001) and local recurrence (1.
98, 1.
66 to 2.
36, P<0.
001).
Close margins were associated with increased distant recurrence (1.
38, 1.
13 to 1.
69, P<0.
001) and local recurrence (2.
09, 1.
39 to 3.
13, P<0.
001) compared with negative margins, after adjusting for receipt of adjuvant chemotherapy and radiotherapy.
In five studies published since 2010, tumour on ink margins were associated with increased distant recurrence (2.
41, 1.
81 to 3.
21, P<0.
001) as were tumour on ink and close margins (1.
44, 1.
22 to 1.
71, P<0.
001) compared with negative margins.
ConclusionsInvolved or close pathological margins after breast conserving surgery for early stage, invasive breast cancer are associated with increased distant recurrence and local recurrence.
Surgeons should aim to achieve a minimum clear margin of at least 1 mm.
On the basis of current evidence, international guidelines should be revised.
Systematic review registrationCRD42021232115.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Breast cancer biomarkers : dynamics during treatment and metastatic progression
Breast cancer biomarkers : dynamics during treatment and metastatic progression
<p dir="ltr">Breast cancer is a major global health challenge as incidence is increasing, and risk of recurrence remains a significant concern for long-term survivors. In an ...
Breast cancer biomarkers : dynamics during treatment and metastatic progression
Breast cancer biomarkers : dynamics during treatment and metastatic progression
<p dir="ltr">Breast cancer is a major global health challenge as incidence is increasing, and risk of recurrence remains a significant concern for long-term survivors. In an ...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...

Back to Top